While the industry is buzzing about the Proposed Rule, let's not forget about the imminent Discharge Community measure of the Impact Act.
What are you doing to ensure your agency aces the Discharge to Community measure? While keeping your home health patients out of the hospital has always been a focus, now, under the Impact Act, you’ll be penalized if you don’t.
Our readmission reduction solution, Medalogix Touch is where it all started. It was our first solution which was conceptualized by our CEO and founder, Dan Hogan, when he owned and operated a home health agency in rural Tennessee. Like all solutions, it was created to solve a problem.
Deloitte recently released a 20-page report on the healthcare industry's current views on post acute care. It's called Viewing post-acute care in a new light--Strategies to drive value. You can download the full report here.
National Healthcare Decisions Day (NHDD) exists to inspire, educate and empower the public and providers about the importance of advance care planning. This is an issue close to our hearts at Medalogix because we know that when patients and their famillies are informed about end-of-life care wishes and status, outcomes and satisfaction are improved. That's the very premise of our end-of-life analytics solution, Medalogix Bridge.
What If we told you that nearly 300 patents you’ve discharged in the last 9 months will soon need your care again? (Dive deeper into this metric by checking out this case study.) Medalogix Nurture will help you understand which ones, so you can be there to give them the additional home health care they need.
We were fortunate to attend J.P. Morgan's annual healthcare conference in early January. It's one of the life science industry’s largest conferences of the year as it brings thousands of investors and executives from around the world to San Francisco where companies present their latest innovations hoping to find their next partner or investor.